Collectively, the aggressive clinicopathological characteristics of ccRCC could further inhibit FDX1 expression, and downregulated expression in primary ccRCC has essential implications for the underlying function of FDX1 in tumorigenesis. Here, FDX1 is linked to nonpapillary renal cell carcinoma.